The Scientist

» science publishing and immunology

Most Recent

Researchers find that scientific papers with shorter titles accrue more citations only if they are very popular. For papers flying under the radar, longer titles fare better.

0 Comments

image: Sex Differences in Immune Response

Sex Differences in Immune Response

By | June 21, 2016

Female mice lacking an immune receptor are better than males at fighting certain viral infections.

0 Comments

image: TS Picks: June 20, 2016

TS Picks: June 20, 2016

By | June 20, 2016

Excellence schmexellence; thinking outside the biomedical box; homeopathy journal sunk by self-citation

1 Comment

image: Breathing Life Into Papers

Breathing Life Into Papers

By | June 12, 2016

Researchers prepare to launch an effort to make the scientific literature more dynamic.

0 Comments

image: E.U. Pushes for Open Access by 2020

E.U. Pushes for Open Access by 2020

By | June 1, 2016

European Union member states agree to an ambitious goal to make all scientific papers freely accessible within four years.

3 Comments

image: Bertozzi the Editor

Bertozzi the Editor

By | June 1, 2016

Stanford University biochemist Carolyn Bertozzi discusses her role at the helm of ACS Central Science, a cross-disciplinary, open-access chemistry journal

0 Comments

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech